DK116659B - Fremgangsmåde til fremstilling af 9α-hydroxy-11β-nitro-1,3,5(10)-østratriener. - Google Patents

Fremgangsmåde til fremstilling af 9α-hydroxy-11β-nitro-1,3,5(10)-østratriener.

Info

Publication number
DK116659B
DK116659B DK569867AA DK569867A DK116659B DK 116659 B DK116659 B DK 116659B DK 569867A A DK569867A A DK 569867AA DK 569867 A DK569867 A DK 569867A DK 116659 B DK116659 B DK 116659B
Authority
DK
Denmark
Prior art keywords
estratrienes
nitro
hydroxy
preparation
Prior art date
Application number
DK569867AA
Other languages
Danish (da)
English (en)
Inventor
A Consonni
B Patelli
R Sciaky
Original Assignee
Farmaceutici Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia filed Critical Farmaceutici Italia
Publication of DK116659B publication Critical patent/DK116659B/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Manufacture And Refinement Of Metals (AREA)
DK569867AA 1966-11-18 1967-11-15 Fremgangsmåde til fremstilling af 9α-hydroxy-11β-nitro-1,3,5(10)-østratriener. DK116659B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT3007766 1966-11-18

Publications (1)

Publication Number Publication Date
DK116659B true DK116659B (da) 1970-02-02

Family

ID=11228982

Family Applications (1)

Application Number Title Priority Date Filing Date
DK569867AA DK116659B (da) 1966-11-18 1967-11-15 Fremgangsmåde til fremstilling af 9α-hydroxy-11β-nitro-1,3,5(10)-østratriener.

Country Status (15)

Country Link
US (1) US3520909A (es)
AT (1) AT271757B (es)
BE (1) BE706686A (es)
CH (1) CH493506A (es)
DE (1) DE1618977B1 (es)
DK (1) DK116659B (es)
ES (1) ES347318A1 (es)
FR (1) FR7064M (es)
GB (1) GB1145437A (es)
GR (1) GR38947B (es)
IL (1) IL28936A (es)
NL (2) NL6715106A (es)
NO (1) NO128023B (es)
SE (1) SE335527B (es)
YU (1) YU31806B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554603A (en) * 1993-09-17 1996-09-10 The United States Of America As Represented By The Department Of Health And Human Services Orally active derivatives of 1,3,5(10)-estratriene

Also Published As

Publication number Publication date
NL135316C (es)
ES347318A1 (es) 1969-02-01
NO128023B (es) 1973-09-17
FR7064M (es) 1969-06-23
BE706686A (es) 1968-05-17
AT271757B (de) 1969-06-10
CH493506A (de) 1970-07-15
GR38947B (el) 1970-01-20
SE335527B (es) 1971-06-01
YU222567A (en) 1973-06-30
GB1145437A (en) 1969-03-12
NL6715106A (es) 1968-05-20
IL28936A (en) 1972-07-26
US3520909A (en) 1970-07-21
DE1618977B1 (de) 1972-07-20
YU31806B (en) 1973-12-31

Similar Documents

Publication Publication Date Title
DK120546B (da) Fremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimidiner.
DK118877B (da) Analogifremgangsmåde til fremstilling af 3,1-benzoxazin-2-oner.
DK119005B (da) Fremgangsmåde til fremstilling af 3-alkoxy-13-alkylgona-1,3,5(10),8,14-penten-17-oner.
DK112523B (da) Fremgangsmåde til fremstilling af 2,3-pyridindiol.
DK116357B (da) Fremgangsmåde til fremstilling af 1,1,1,2,2-pentafluor-3-chlorpropan.
DK120347B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepin-4-oxider.
DK115184B (da) Fremgangsmåde til fremstilling af 6,7-benzomorphaner.
DK123169B (da) Fremgangsmåde til fremstilling af 2,5-dichlor-4-alkylmercaptophenoler.
DK114273B (da) Fremgangsmåde til fremstilling af α-methyl-α-amino-β-(3,4-disubstituerede-phenyl)-propionitriler.
DK115622B (da) Fremgangsmåde til fremstilling af 3-oxogona-4,9,11-triener.
DK120131B (da) Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener.
DK116594B (da) Fremgangsmåde til fremstilling af 4,1,5-benzoxadiazociner.
DK126936B (da) Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener.
DK118406B (da) Fremgangsmåde til fremstilling af 3-alkynyloxy- og 3-alkenyloxy-4-sulfanilamido-1,2,5-thiadiazoler.
DK112031B (da) Fremgangsmåde til fremstilling af 3,20-dioxo-17α-methyl-19-nor-pregna-4,9,11-trien.
DK127418B (da) Fremgangsmåde til fremstilling af 13-alkyl-gona-1,3,5(10),6,8,14-hexaener.
DK117955B (da) Analogifremgangsmåde til fremstilling af N<4>-acrylerede 1-halogenbenzen-2,4-disulfonamider.
DK120845B (da) Fremgangsmåde til fremstilling af 3β-formoxy-15α-halogen-14β-hydroxy-5β-card-20(22)-enolider.
DK116368B (da) Fremgangsmåde til fremstilling af 2,3-dihydro-2,2,4-trimethyl-7-benzofuranol.
DK113917B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetrachlorcyclohexanon.
DK116659B (da) Fremgangsmåde til fremstilling af 9α-hydroxy-11β-nitro-1,3,5(10)-østratriener.
DK119108B (da) Fremgangsmåde til fremstilling af C-D-trans-3-hydroxy-13-alkyl-17-oxogona-1,3,5(10),6,8-pentener.
DK126688B (da) Fremgangsmåde til fremstilling af 13-alkyl-gona-1,3,5(10),7-tetraener.
DK127327B (da) Fremgangsmåde til fremstilling af 1,2,3,4-tetrahydronaphthalen-2-on-derivater.
DK122389B (da) Analogifremgangsmåde til fremstilling af chlorbenzen-2,4-disulfonamider.